Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
SWISS biotech company Actelion has turned back to prospective bidder Johnson & Johnson (J&J) for exclusive talks about a "strategic transaction", in an about-turn that appears to sideline rival suitor Sanofi.
Actelion said in a brief statement on Wednesday that it